Implantable Drug Delivery Device Market Report：the market size is projected to reach USD 0.69 billion by 2031

An Implantable Drug Delivery Device is a fully implanted medical device used for long-term intravenous therapy, such as chemotherapy, parenteral nutrition, and repeated blood sampling. It consists of a small reservoir (port) placed under the skin, usually in the chest, connected to a catheter that enters a central vein. This design allows healthcare professionals to access the bloodstream without repeated needle insertions into peripheral veins, reducing discomfort and the risk of vascular complications.

Implantable Drug Delivery Device are commonly used for patients requiring frequent or prolonged intravenous treatments, offering advantages such as improved patient mobility, a lower infection risk compared to external catheters, and enhanced durability. The device is accessed through the skin using a special non-coring needle, ensuring a secure and reliable administration route. Advances in biomaterials and catheter technology have improved the safety and efficiency of TIVADs, making them a standard choice for patients undergoing long-term infusion therapy.

The Implantable Drug Delivery Device market is driven by the increasing prevalence of chronic diseases such as cancer, which requires long-term intravenous therapy. The rising global cancer burden, coupled with the growing demand for chemotherapy and parenteral nutrition, has significantly boosted Implantable Drug Delivery Device adoption. Additionally, advancements in biomaterials and catheter technologies have improved device safety, reducing infection risks and enhancing patient comfort. Healthcare infrastructure improvements, increased awareness, and expanding insurance coverage further contribute to market growth, especially in emerging economies where access to advanced medical treatments is improving.

However, the market faces several challenges, including high device costs and procedural expenses, which limit accessibility, particularly in developing regions. Complications such as infections, thrombosis, and catheter malfunctions remain concerns, requiring strict adherence to insertion and maintenance protocols. Moreover, the need for trained medical professionals for implantation and management can hinder widespread adoption. Regulatory requirements and lengthy approval processes for new Implantable Drug Delivery Device innovations also pose market entry barriers. Despite these challenges, continued technological advancements and increasing healthcare investments are expected to drive market expansion in the coming years.

According to the new market research report “Implantable Drug Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the global Implantable Drug Delivery Device market size is projected to reach USD 0.69 billion by 2031, at a CAGR of 3.0% during the forecast period.

• Global Implantable Drug Delivery Device MarketSize(US$ Million), 2020-2031

Source: QYResearch, "Implantable Drug Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

• Global Implantable Drug Delivery Device Top12Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)

Source: QYResearch, "Implantable Drug Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

According to QYResearch Top Players Research Center, the global key manufacturers of Implantable Drug Delivery Device include BD, B. Braun, ICU Medical, AngioDynamics, Linhua Medical, etc. In 2024, the global top five players had a share approximately 83.54% in terms of revenue.

About The Authors

Zhang Xiao - Lead Author

Email: zhangxiao@qyresearch.com

Zhang Xiao is a market senior analyst specializing in medical device, pharma, Lab consumable. Zhang  Xiao has 8 years’ experience in medical device and  pharma market analysis, and focuses on medical device and consumables (imaging equipment, medical consumables, wearable medical equipment, medical robots, home care equipment, dental equipment, implant equipment, operating room equipment, in vitro diagnostics, etc.) and drugs (API, finished drugs, patented drugs, blood products , vaccines, etc.) . She is engaged in the development of technology and market reports and is also involved in custom projects.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp